Company news
Prescient Therapeutics Limited news in 2020
Prescient Therapeutics Limited's news releases, calls and decks from 2020, newest first.
Prescient Receives $1.03m R&D Tax Rebate
November 10, 2020
September 2020 Quarterly Update and Appendix 4C
October 19, 2020
Response to ASX Query
September 16, 2020
PTX Raises $7 million via Strongly Supported Placement
August 25, 2020
Appendix 4E and 2020 Annual Report
August 25, 2020
Successful SPP Closed Early
August 18, 2020
Extension of Share Purchase Plan
August 14, 2020
PTX Announces Cell Therapy Collaboration with Peter Mac
August 13, 2020
PTX-100 progresses to next cohort in basket clinical study
August 11, 2020
PTX-200 AML Trial Progresses to Next Dose Level
August 3, 2020
June 2020 Quarterly Update and Appendix 4C
July 21, 2020
2 PTX Assets Chosen in Doherty Institute COVID-19 Program
July 21, 2020
Trading Pause
July 20, 2020
Reinstatement to Official Quotation
May 25, 2020
PTX signs next-gen anti-cancer platform from Penn & Oxford
May 25, 2020
Voluntary Suspension
May 25, 2020
Pause in Trading
May 21, 2020
PTX-100 progresses to new dose, adds new site
April 21, 2020
March 2020 Quarterly Update and Appendix 4C
April 15, 2020
December 2019 Appendix 4C - Quarterly
January 31, 2020
Decks in 2020
- Shareholder Meeting (November 2020)
Shareholder meeting · 32 slides · Nov 24, 2020
- Investor Presentation (May 2020)
Investor deck · 36 slides · May 26, 2020